Immuneering Corp Cl A (IMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IMRX | AMGN | VRTX | REGN | GSK |
| Company | Immuneering Corp Cl A | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 1.2400 | 334.56 | 493.14 | 1,067.54 | 39.63 |
| High | 1.2999 | 338.94 | 502.97 | 1,091.31 | 40.12 |
| Low | 1.2000 | 333.28 | 492.17 | 1,067.54 | 39.58 |
| Last | 1.2400 | 334.85 | 495.26 | 1,078.63 | 39.86 |
| Change | +0.0100 | +0.55 | +3.00 | +14.44 | +0.79 |
| % Change | +0.81% | +0.16% | +0.61% | +1.36% | +2.02% |
| Volume | 65,100 | 1,515,400 | 774,100 | 380,800 | 3,064,100 |
| 20-Day Average Volume | 284,480 | 1,897,160 | 1,086,435 | 405,595 | 2,816,320 |
| Previous Close | 1.2300 | 334.30 | 492.26 | 1,064.19 | 39.07 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.1890 | 324.73 | 485.57 | 1,064.57 | 38.94 |
| 20-Day Raw Stochastic | 48.72% | 70.54% | 77.01% | 70.86% | 88.77% |
| 20-Day Relative Strength | 45.35% | 65.60% | 65.12% | 59.08% | 48.94% |
| Weighted Alpha | -72.46 | +41.43 | +44.06 | +43.97 | +9.27 |
| Today's Opinion | 88% Sell | 100% Buy | 100% Buy | 100% Buy | 40% Sell |
| Previous Opinion | 88% Sell | 100% Buy | 100% Buy | 100% Buy | 40% Sell |
| Last Month's Opinion | 88% Sell | 100% Buy | 100% Buy | 100% Buy | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +11.71% since 07/19/24 | +1.07% since 07/19/24 | +0.75% since 07/19/24 | +1.41% since 07/19/24 | +1.30% since 07/19/24 |
| Low | 1.1200 on 07/22/24 | 330.34 on 07/24/24 | 486.25 on 07/24/24 | 1,052.81 on 07/24/24 | 38.78 on 07/23/24 |
| High | 1.2999 on 07/26/24 | 346.85 on 07/25/24 | 503.99 on 07/25/24 | 1,102.95 on 07/25/24 | 40.12 on 07/26/24 |
| 1-Month | |||||
| %Chg | -10.14% since 06/26/24 | +7.04% since 06/26/24 | +4.49% since 06/26/24 | +0.89% since 06/26/24 | +2.55% since 06/26/24 |
| Low | 1.0500 on 07/02/24 | 306.11 on 07/03/24 | 466.01 on 07/03/24 | 1,011.67 on 07/03/24 | 37.81 on 07/02/24 |
| High | 1.4400 on 06/28/24 | 346.85 on 07/25/24 | 503.99 on 07/25/24 | 1,106.16 on 07/12/24 | 40.12 on 07/26/24 |
| 3-Month | |||||
| %Chg | -15.65% since 04/26/24 | +24.03% since 04/26/24 | +24.60% since 04/26/24 | +22.13% since 04/26/24 | -3.04% since 04/26/24 |
| Low | 1.0500 on 07/02/24 | 268.99 on 04/29/24 | 391.70 on 04/30/24 | 883.20 on 04/29/24 | 37.81 on 07/02/24 |
| High | 2.0100 on 06/11/24 | 346.85 on 07/25/24 | 503.99 on 07/25/24 | 1,106.16 on 07/12/24 | 45.92 on 05/15/24 |
| 6-Month | |||||
| %Chg | -79.87% since 01/26/24 | +7.40% since 01/26/24 | +15.13% since 01/26/24 | +14.74% since 01/26/24 | +2.02% since 01/26/24 |
| Low | 1.0500 on 07/02/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 37.81 on 07/02/24 |
| High | 7.6800 on 03/04/24 | 346.85 on 07/25/24 | 503.99 on 07/25/24 | 1,106.16 on 07/12/24 | 45.92 on 05/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 36,473 | 179,330,224 | 127,029,184 | 117,258,816 | 80,971,872 |
| Shares Outstanding, K | 29,653 | 536,435 | 258,053 | 110,186 | 2,072,482 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 37,725,000,000 |
| Annual Net Income | -53,470,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 6,129,940,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 9,337,020,000 |
| Last Quarter Net Income | -14,310,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | 1,326,430,000 |
| 60-Month Beta | -0.61 | 0.58 | 0.39 | 0.13 | 0.64 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.49 on 05/07/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | 1.09 on 05/01/24 |
| Latest Earnings Date | 08/01/24 | 08/06/24 | 08/01/24 | 08/01/24 | 07/31/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.377 on 05/16/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 05/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 18.01 | 32.59 | 28.59 | 9.73 |